Related Experiment Video
Updated: Oct 24, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
Severe ocular mpox in an immunocompetent patient
Noelia Ferreira Aparicio1, Alejandra Herrera2, Soledad Mendoza2
1Service of Internal Medicine, Hospital General de Fuerteventura, Las Palmas, Canary Islands, Spain.
Abstract:
Mpox, formerly known as monkeypox, is caused by Monkeypox virus (MPXV) and has been associated since 2022 with exanthematous illness in men who have sex with men (MSM), including HIV-negative individuals without prior MPXV vaccination.1,2 The clinical course is usually self-limited, with cutaneous and mucosal involvement.4,10,12 Severe forms, including keratoconjunctivitis and corneal ulcers, are uncommon and have mainly been linked to immunosuppression.2,3,5,10,12,14 We report a 20-year-old MSM male, HIV-negative, immunocompetent, and using pre-exposure prophylaxis (PrEP). He presented with generalized exanthema, right ocular pain, conjunctival injection, tearing, and periorbital cellulitis.1,2,5,10,14 Ophthalmologic evaluation confirmed severe keratoconjunctivitis with progressive corneal ulcers.5-7,10,11,14 MPXV PCR was positive in skin and corneal samples.1,2,10,14 This case highlights the potential for severe ocular disease in a young, otherwise healthy patient and underscores the need for high clinical suspicion, early ophthalmologic assessment, and timely antiviral therapy.2,4,10,15.
Related Concept Videos
Cryptococcal Meningitis
Microbiome of the Eye
Rocky Mountain Spotted Fever
Glaucoma: Overview
Hypersensitivity Reactions: Immune-Complex Reactions

